Bone marrow and blood cells as alternative sources of hematopoietic progenitors after failure of a first collection: A single institution retrospective study

Transplantation

Volumn 61, Issue 3, 1996, Pages 518-522

  Aurran Schleinitz, Thérèse ^a   Chabannon, Christian ^a   Faucher, Catherine ^a   Viens, Patrice ^a   Cournier, Sandra ^a   Maraninchi, Dominique ^a   Blaise, Didier ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; APHERESIS; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; STEM CELL;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD CELLS; BLOOD COMPONENT REMOVAL; BONE MARROW; BONE MARROW CELLS; COLONY-FORMING UNITS ASSAY; CRYOPRESERVATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030025342     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602150-00037     Document Type: Article

References (10)

1. Kretchmar AL, Conover WR. A difference between spleen-derived and bone marrow-derived colony forming units in ability to protect lethally irradiated mice. Blood 1970; 36: 772.
2. Dreger P, Suttorp M, Haferlach T, Löffler H, Schmitz N, Schroyens W. Allogeneic granulocyte-colony stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404.
3. Molina L, Chabannon C, Viret F, et al. G-CSF mobilized allogeneic peripheral blood stem cells for rescue of graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remission. Blood 1995; 85: 1678.
4. Faucher C, Le Coroller A-G, Biaise D, et al. Comparison of G-CSF primed peripheral blood progenitor and bone marrow autotransplantations: clinical assessment and cost-effectiveness study. Bone Marrow Transplant 1994; 14: 895.
5. Brugger W, Bross KJ, Glatt MG, Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636.
6. Bender JG, Williams SF, Myers S, et al. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant 1992; 10: 281.
7. Haas R, Möhle R, Frühauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787.
8. Chabannon C, Le Coroller AG, Faucher C, et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 1995; 4: 171.
9. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329.
10. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825.